VC3-22385-45547
4 vaccinations
3 coded responses
46 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 231 / VA
- Registered
- 2020-12-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-19
Registered in v-safe
-
2020-12-19
Dose 1 — Pfizer-BioNTech
- 2020-12-19
- 2020-12-20
- 2020-12-21
- 2020-12-22
- 2020-12-24
- 2020-12-25
- 2020-12-28
- 2021-01-04
-
2021-01-08
Dose 2 — Pfizer-BioNTech
- 2021-01-08
-
2021-01-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-10
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessFree text: Axillary lymphadenopathy on the side of the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-01-11
Survey response — days 1–6 daily, dose 2MedDRA: Lymphadenopathy — Feeling: Good · Site: PainFree text: Improving axillary lymphadenopathy on the same side as the vaccineMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-12
- 2021-01-13
- 2021-01-14
- 2021-01-15
- 2021-01-22
- 2021-01-30
- 2021-02-08
- 2021-02-12
- 2021-02-19
- 2021-04-09
- 2021-07-09
-
2021-09-27
Dose 3 — Pfizer-BioNTech
-
2021-09-29
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Headache, Muscle or body achesAdult check-in
- 2021-09-30
- 2021-10-01
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-12-27
- 2022-03-30
-
2022-09-11
Dose 4 — Pfizer-BioNTech
-
2022-09-12
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
- 2022-09-17
- 2022-09-18
- 2022-09-25
- 2022-10-02
- 2022-10-09
- 2022-10-16
- 2022-10-23
-
2022-12-11
Survey response — 3 months, dose 4MedDRA: Abortion spontaneous — Feeling: GoodFree text: MiscarriageMedDRA releases: 2024-11 · check-in free text available
- 2023-03-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-19 | Pfizer-BioNTech | |
| 2 | 2021-01-08 | Pfizer-BioNTech | |
| 3 | 2021-09-27 | Pfizer-BioNTech | No |
| 4 | 2022-09-11 | Pfizer-BioNTech | No |
Free text
Release 1 — days 1–6 daily, dose 2
Systemic reaction (other): Axillary lymphadenopathy on the side of the vaccine
Systemic reaction (other): Improving axillary lymphadenopathy on the same side as the vaccine
Release 12 — 3 months, dose 4
Symptoms: Miscarriage
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | · | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release